Great debate: clopidogrel should now replace aspirin for long-term secondary prevention of coronary artery disease.

Berry C, Valgimigli M, Patrono C, Gragnano F, Landi A, Gorog DA

Open source

DOI
10.1093/eurheartj/ehag673
Published
2026 Aug 27
Container
European heart journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag673,
  title = {Great debate: clopidogrel should now replace aspirin for long-term secondary prevention of coronary artery disease.},
  author = {Berry C and Valgimigli M and Patrono C and Gragnano F and Landi A and Gorog DA},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehag673},
  url = {https://doi.org/10.1093/eurheartj/ehag673}
}

RIS

TY  - JOUR
TI  - Great debate: clopidogrel should now replace aspirin for long-term secondary prevention of coronary artery disease.
AU  - Berry C
AU  - Valgimigli M
AU  - Patrono C
AU  - Gragnano F
AU  - Landi A
AU  - Gorog DA
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehag673
UR  - https://doi.org/10.1093/eurheartj/ehag673
ER  - 

APA

C, B., M, V., C, P., F, G., A, L., & DA, G. (2026). Great debate: clopidogrel should now replace aspirin for long-term secondary prevention of coronary artery disease.. European heart journal. https://doi.org/10.1093/eurheartj/ehag673

Source records